Adaptive Biotechnologies, based in South San Francisco, CA, is a leading company in the field of Immune Medicine. They harness the power of the adaptive immune system to detect and fight diseases, revolutionizing the way we detect and treat illnesses. With their innovative products and data-driven approach, they aim to make diseases a thing of the past.
Through their Immune Medicine Platform, Adaptive Biotechnologies decodes and deploys the adaptive immune system, providing rich immune receptor data that informs clinical trials and the development of transformative medicines. Their focus areas include Minimal Residual Disease assessment, clinical testing, adaptive immunosequencing, drug discovery, TCR therapeutics, and antibody therapeutics.
Generated from the website